510(k) K150281
K150281 is an FDA 510(k) premarket notification submitted by Nova Biomedical Corporation for the device "StatStrip Glucose Hospital Meter". The FDA issued a decision of Substantially Equivalent on May 6, 2015. The device falls under product code PZI (Prescription Use Blood Glucose Meter For Near-Patient Testing), a Class II device regulated under 21 CFR 862.1345. Nova Biomedical Corporation has 39 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 6, 2015
- Date Received
- Feb 5, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Prescription Use Blood Glucose Meter For Near-Patient Testing
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)
Intended for use in near-patient testing settings for in vitro diagnostic, multiple-patient use for the quantitative determination of glucose throughout all hospital and all professional healthcare settings for use in determining dysglycemia.
Need the full FDA record for Nova Biomedical Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.